LAG3 and bladder transitional cell carcinoma: Subgroup analyses based on tumor type indicated that higher LAG3 expression was significantly correlated with worse survival outcomes in BLCA, CESE, ESCA, KIRC, LIHC, PAAD, SARC, and SKCM.